ViewRay Inc
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $0.0108
- Today's High:
- $0.015
- Open Price:
- $0.0121
- 52W Low:
- $0.009
- 52W High:
- $4.96
- Prev. Close:
- $0.012
- Volume:
- 2048785
Company Statistics
- Market Cap.:
- $4.59 million
- Book Value:
- 0.301
- Revenue TTM:
- $105.86 million
- Operating Margin TTM:
- -101.52%
- Gross Profit TTM:
- $10.05 million
- Profit Margin:
- -104.3%
- Return on Assets TTM:
- -25.29%
- Return on Equity TTM:
- -108.91%
Company Profile
ViewRay Inc had its IPO on 2015-12-28 under the ticker symbol VRAY.
The company operates in the Healthcare sector and Healthcare Equipment & Supplies industry. ViewRay Inc has a staff strength of 295 employees.
Stock update
Shares of ViewRay Inc opened at $0.01 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $0.01 - $0.02, and closed at $0.01.
This is a -3.33% slip from the previous day's closing price.
A total volume of 2,048,785 shares were traded at the close of the day’s session.
In the last one week, shares of ViewRay Inc have slipped by -13.43%.
ViewRay Inc's Key Ratios
ViewRay Inc has a market cap of $4.59 million, indicating a price to book ratio of 7.9871 and a price to sales ratio of 9.4214.
In the last 12-months ViewRay Inc’s revenue was $105.86 million with a gross profit of $10.05 million and an EBITDA of $-102732000. The EBITDA ratio measures ViewRay Inc's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, ViewRay Inc’s operating margin was -101.52% while its return on assets stood at -25.29% with a return of equity of -108.91%.
In Q1, ViewRay Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 19.4%.
ViewRay Inc’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 0
- PEG
- 0
Its diluted EPS in the last 12-months stands at $-0.26 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into ViewRay Inc’s profitability.
ViewRay Inc stock is trading at a EV to sales ratio of 8.6207 and a EV to EBITDA ratio of -7.7613. Its price to sales ratio in the trailing 12-months stood at 9.4214.
ViewRay Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $233.16 million
- Total Liabilities
- $166.77 million
- Operating Cash Flow
- $-1177000.00
- Capital Expenditure
- $1.18 million
- Dividend Payout Ratio
- 0%
ViewRay Inc ended 2024 with $233.16 million in total assets and $0 in total liabilities. Its intangible assets were valued at $233.16 million while shareholder equity stood at $55.26 million.
ViewRay Inc ended 2024 with $0 in deferred long-term liabilities, $166.77 million in other current liabilities, 1824000.00 in common stock, $-873321000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $81.29 million and cash and short-term investments were $81.29 million. The company’s total short-term debt was $80,692,000 while long-term debt stood at $0.
ViewRay Inc’s total current assets stands at $193.57 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $47.53 million compared to accounts payable of $30.13 million and inventory worth $42.19 million.
In 2024, ViewRay Inc's operating cash flow was $-1177000.00 while its capital expenditure stood at $1.18 million.
Comparatively, ViewRay Inc paid $0 in dividends in 2024.
Other key metrics
- Current Trading Price
- $0.01
- 52-Week High
- $4.96
- 52-Week Low
- $0.009
- Analyst Target Price
- $1
ViewRay Inc stock is currently trading at $0.01 per share. It touched a 52-week high of $4.96 and a 52-week low of $4.96. Analysts tracking the stock have a 12-month average target price of $1.
Its 50-day moving average was $0.09 and 200-day moving average was $2.27 The short ratio stood at 1.7 indicating a short percent outstanding of 0%.
Around 1735.9% of the company’s stock are held by insiders while 7459.6% are held by institutions.
Frequently Asked Questions About ViewRay Inc
Similar Industry Stocks (Healthcare Equipment & Supplies)
Most Active
Top Gainers
Top Losers
About
ViewRay, Inc. designs, manufactures, and markets magnetic resonance imaging (MRI) guided radiation therapy systems to image and treat cancer patients in the United States, Italy, France, Taiwan, the United Kingdom, and internationally. It provides MRIdian, which is an MRI guided radiation therapy system that addresses beam distortion, skin toxicity, and other concerns. The company serves university research and teaching hospitals, community hospitals, private practices, government institutions, and freestanding cancer centers through a network of direct sales force and distributors. ViewRay, Inc. was founded in 2004 and is headquartered in Denver, Colorado. On July 16, 2023, ViewRay, Inc., alongwith its affiliate, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.